| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,300 |
9,954 |
$2.00M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,998 |
5,888 |
$1.66M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,130 |
995 |
$880K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,744 |
1,501 |
$565K |
| 70450 |
Computed tomography, head or brain; without contrast material |
860 |
740 |
$233K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,397 |
2,178 |
$194K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,383 |
2,804 |
$148K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,899 |
2,657 |
$121K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,589 |
1,473 |
$102K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,882 |
2,370 |
$94K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,799 |
1,336 |
$94K |
| 71045 |
Radiologic examination, chest; single view |
2,187 |
1,905 |
$92K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,021 |
2,680 |
$86K |
| 80053 |
Comprehensive metabolic panel |
9,887 |
8,102 |
$75K |
| 85027 |
|
11,819 |
9,440 |
$67K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,366 |
2,084 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,379 |
1,045 |
$58K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
791 |
499 |
$55K |
| 71046 |
Radiologic examination, chest; 2 views |
827 |
723 |
$53K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,590 |
1,279 |
$39K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,025 |
1,810 |
$27K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
101 |
88 |
$22K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
31 |
27 |
$21K |
| 96376 |
|
292 |
223 |
$16K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
201 |
136 |
$16K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
735 |
199 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
587 |
541 |
$14K |
| 80061 |
Lipid panel |
1,337 |
1,222 |
$14K |
| 81001 |
|
4,710 |
4,017 |
$13K |
| 87634 |
|
253 |
238 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
795 |
546 |
$13K |
| 80306 |
|
579 |
475 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
6,182 |
5,012 |
$12K |
| 83690 |
|
2,145 |
1,785 |
$12K |
| 84484 |
|
1,917 |
1,474 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
274 |
210 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
335 |
242 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
555 |
526 |
$9K |
| 83880 |
|
537 |
462 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,450 |
1,228 |
$9K |
| 83605 |
|
1,030 |
836 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,109 |
906 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,003 |
926 |
$7K |
| 71250 |
|
28 |
24 |
$6K |
| 81025 |
|
918 |
778 |
$6K |
| 83735 |
|
1,313 |
849 |
$6K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
105 |
100 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
13 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
12 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
166 |
136 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
113 |
103 |
$4K |
| 87040 |
|
543 |
428 |
$4K |
| 85610 |
|
1,439 |
1,049 |
$4K |
| 74018 |
|
57 |
51 |
$4K |
| 84439 |
|
286 |
256 |
$2K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
134 |
25 |
$2K |
| 87077 |
|
279 |
240 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
12 |
$2K |
| 87186 |
|
251 |
212 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
197 |
158 |
$2K |
| 73110 |
|
19 |
19 |
$2K |
| 84703 |
|
185 |
163 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
232 |
214 |
$920.31 |
| 73610 |
|
12 |
12 |
$832.06 |
| 85730 |
|
281 |
243 |
$781.48 |
| 73630 |
|
12 |
12 |
$733.34 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
27 |
27 |
$417.32 |
| 82607 |
|
29 |
27 |
$377.80 |
| 86140 |
|
84 |
73 |
$305.49 |
| J3490 |
Unclassified drugs |
636 |
520 |
$289.28 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
17 |
13 |
$288.81 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
17 |
13 |
$288.81 |
| 85652 |
|
101 |
83 |
$234.15 |
| J7050 |
Infusion, normal saline solution, 250 cc |
26 |
13 |
$214.78 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$193.10 |
| 85379 |
|
13 |
12 |
$67.16 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
25 |
24 |
$59.28 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
38 |
25 |
$54.34 |
| 87210 |
|
13 |
13 |
$49.90 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
165 |
156 |
$0.00 |
| 82077 |
|
17 |
14 |
$0.00 |